European Journal of Rheumatology
Original Article

Serum calreticulin as a novel biomarker of juvenile idiopathic arthritis disease activity

1.

Department of Rheumatology, Rehabilitation and Physical Medicine, Benha University School of Medicine, Benha, Egypt

2.

Department of Microbiology and Immunology, Benha University School of Medicine, Benha, Egypt

3.

Deaprtment of Diagnostic Radiology, Benha University School of Medicine, Benha, Egypt

Eur J Rheumatol 2017; 4: 19-23
DOI: 10.5152/eurjrheum.2017.160071
Read: 105 Downloads: 20 Published: 03 September 2019

Abstract

Objective: This study aimed to investigate the relations between calreticulin (CRT) serum level and both disease activity and severity parameters in juvenile idiopathic arthritis (JIA).

 

Material and Methods: In this study, 60 children with JIA and 50 age-and-sex-matched healthy subjects were enrolled. The assessment of the disease activity was done using juvenile arthritis disease activity score 27 (JADAS-27). The assessment of disease severity was done via gray-scale ultrasonography (US) and power Doppler US (PDUS). Enzyme-linked immunosorbent assay (ELISA) was used to assay the serum level of human CRT.

 

Results: The mean serum CRT levels in JIA patients was 8.6±1.2 ng/mL and showed a highly significant increase (p=0.001) as compared to the mean serum levels in the controls (5.02±0.77 ng/mL). There were statistically significant positive correlations between the serum CRT levels and disease duration, tender joint count, swollen joint count, visual analog scale, erythrocyte sedimentation rate, JADAS-27, C-reactive protein, rheumatoid factor titer, and ultrasonographic grading for synovitis and neovascularization.

 

Conclusion: Elevated serum CRT levels in JIA patients and its correlations with JIA disease activity and severity parameters signified that CRT might be used as a novel biomarker for disease activity and severity in JIA.

Files
ISSN2147-9720 EISSN 2148-4279